Results 1 to 10 of about 269,411 (265)
Clinical impact of vivax malaria: A collection review.
PLoS Medicine, 2022 BackgroundPlasmodium vivax infects an estimated 7 million people every year. Previously, vivax malaria was perceived as a benign condition, particularly when compared to falciparum malaria.
Aung Pyae Phyo +3 more
doaj +2 more sources
Severe vivax malaria trends in the last two years: a study from a tertiary care centre, Delhi, India
Annals of Clinical Microbiology and Antimicrobials, 2020 Background Plasmodium vivax, once considered benign species, is recently being recognised to be causing severe malaria like Plasmodium falciparum. In the present study, the authors report the trends in malaria severity in P.
Monika Matlani +4 more
doaj +2 more sources
Growing evidence of Plasmodium vivax across malaria-endemic Africa. [PDF]
PLoS Neglected Tropical Diseases, 2019 Effective malaria control strategies require an accurate understanding of the epidemiology of locally transmitted Plasmodium species. Compared to Plasmodium falciparum infection, Plasmodium vivax has a lower asexual parasitaemia, forms dormant liver ...
Katherine A Twohig +8 more
doaj +2 more sources
Clinical and epidemiological characterization of severe Plasmodium vivax malaria in Gujarat, India
Virulence, 2020 The mounting evidence supporting the capacity of Plasmodium vivax to cause severe disease has prompted the need for a better characterization of the resulting clinical complications. India is making progress with reducing malaria, but epidemics of severe
Anupkumar R. Anvikar +11 more
doaj +2 more sources
Infectious Diseases of Poverty, 2018 Background Plasmodium vivax is the most geographically widespread species among human malaria parasites. Immunopathological studies have shown that platelets are an important component of the host innate immune response against malaria infections.
Cho Naing, Maxine A. Whittaker
doaj +2 more sources
Costs Associated with Malaria in Pregnancy in the Brazilian Amazon, a Low Endemic Area Where Plasmodium vivax Predominates. [PDF]
, 2016 BACKGROUND: Information on costs associated with malaria in pregnancy (MiP) in low transmission areas where Plasmodium vivax predominates is so far missing. This study estimates health system and patient costs of MiP in the Brazilian Amazon.
Bardají, A +7 more
core +16 more sources
Plasmodium vivax: the potential obstacles it presents to malaria elimination and eradication
Tropical Diseases, Travel Medicine and Vaccines, 2022 Initiatives to eradicate malaria have a good impact on P. falciparum malaria worldwide. P. vivax , however, still presents significant difficulties. This is due to its unique biological traits, which, in comparison to P.
K. Habtamu, B. Petros, G. Yan
semanticscholar +1 more source
The prevention and treatment of Plasmodium vivax malaria
PLoS Medicine, 2021 Cindy S Chu and co-authors review options for diagnosis, safe and radical cure, and relapse prevention of Plasmodium Vivax.
C. Chu, N. White
semanticscholar +1 more source
Village malaria workers for the community-based management of vivax malaria
The Lancet Regional Health - Southeast Asia, 2023 Summary: In Cambodia, malaria cases are on a trajectory towards the goal of malaria elimination by 2025. Vivax malaria is difficult to eliminate because of hypnozoites that can cause relapse.
Bipin Adhikari +6 more
doaj +1 more source
PLoS Medicine, 2021 Background A very large biomass of intact asexual-stage malaria parasites accumulates in the spleen of asymptomatic human individuals infected with Plasmodium vivax. The mechanisms underlying this intense tropism are not clear.
Steven Kho +31 more
semanticscholar +1 more source